ESTRO Brachytherapy for Prostate Cancer 2018

First page Table of contents Previous page 444 Next page Last page

UK 19Gy database: bRFS: (n=310)

Risk groups

All patients

Low

Inter

High

bPFS

bPFS

Months

Months

Overall 2-year bPFS: 94% High-risk (88): 93% Inter-risk (186): 94% Low-risk (36): 100% (p = 0.26)

Made with FlippingBook - Online catalogs